Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

3D-Druck von ultrafeinen Geweben im Weltraum für Anti-Aging-Lösungen auf der Erde
Projektleitung: Goswami Nandu
Laufzeit: 01.04.2023 - 31.03.2028
Geldgeber: Europäische Kommission

Antigenpräsentation und Immunopathologie in Herzinsuffizienz.
Projektleitung: Sattler Susanne
Laufzeit: 01.12.2022 - 30.11.2026
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

31.03.2023:

Mead, ME; de, Castro, PA; Steenwyk, JL; Gangneux, JP; Hoenigl, M; Prattes, J; Rautemaa-Richardson, R; Guegan, H; Moore, CB; Lass-Flörl, C; Reizine, F; Valero, C; Van, Rhijn, N; Bromley, MJ; Rokas, A; Goldman, GH; Gago, S, , ECMM, CAPA, Study, Group COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses.
Microbiol Spectr. 2023; e0512822 Doi: 10.1128/spectrum.05128-22
PubMed FullText FullText_MUG

 

31.03.2023:

Bethel, MA; Sourij, H; Stevens, SR; Hannan, K; Lokhnygina, Y; Adler, AI; Peterson, ED; Holman, RR; Lopes, RD Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
Cardiovasc Diabetol. 2023; 22(1):72 Doi: 10.1186/s12933-023-01802-x
PubMed FullText FullText_MUG

 

29.03.2023:

Schaffler-Schaden, D; Stöllinger, L; Avian, A; Terebessy, A; Scott, AM; Streit, S; Piccoliori, G; Zelko, E; Huter, S; Mergenthal, K; Bachler, H; Flamm, M; Siebenhofer, A Gender Differences in Perceived Working Conditions of General Practitioners During the COVID-19 Pandemic-a Cross-Sectional Study.
J Gen Intern Med. 2023; 1-8. Doi: 10.1007/s11606-023-08166-8 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

29.03.2023:

Lang-Illievich, K; Klivinyi, C; Lasser, C; Brenna, CTA; Szilagyi, IS; Bornemann-Cimenti, H Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
Nutrients. 2023; 15(6): Doi: 10.3390/nu15061350
PubMed FullText FullText_MUG

 

27.03.2023:

Buttia, C; Llanaj, E; Raeisi-Dehkordi, H; Kastrati, L; Amiri, M; Mecani, R; Taneri, PE; Ochoa, SAG; Raguindin, PF; Wehrli, F; Khatami, F; Espinola, OP; Rojas, LZ; de Mortanges, AP; Macharia-Nimietz, EF; Alijla, F; Minder, B; Leichtle, AB; Luethi, N; Ehrhard, S; Que, YA; Fernandes, LK; Hautz, W; Muka, T Prognostic models in COVID-19 infection that predict severity: a systematic review
EUR J EPIDEMIOL. 2023; Doi: 10.1007/s10654-023-00973-x
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Zewinger, S; Reiser, J; Jankowski, V; Alansary, D; Hahm, E; Triem, S; Klug, M; Schunk, SJ; Schmit, D; Kramann, R; Korbel, C; Ampofo, E; Laschke, MW; Selejan, SR; Paschen, A; Herter, T; Gaul, S; Silbernagel, G; Sester, M; Sester, U; Assmann, G; Bals, R; Kostner, G; Jahnen-Dechent, W; Menger, MD; Rohrer, L; Marz, W; Bohm, M; Jankowski, J; Kopf, M; Latz, E; Niemeyer, BA; Fliser, D; Laufs, U; Speer, T Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form
NAT IMMUNOL. 2023; Doi: 10.1038/s41590-023-01424-1
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Ahangari, F; Price, NL; Malik, S; Chioccioli, M; Barnthaler, T; Adams, TS; Kim, J; Pradeep, SP; Ding, SZ; Cosmos, CC; Rose, KAS; McDonough, JE; Aurelien, NR; Ibarra, G; Omote, N; Schupp, JC; DeIuliis, G; Nunez, JAV; Sharma, L; Ryu, C; Cruz, CSD; Liu, XR; Prasse, A; Rosas, I; Bahal, R; Fernandez-Hernando, C; Kaminski, N microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis
JCI INSIGHT. 2023; 8(4): e158100 Doi: 10.1172/jci.insight.158100
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Heller, S; Battelino, T; Bailey, TS; Pieber, TR; Hovelmann, U; Plum-Morschel, L; Melgaard, AE; Aronson, R; DiMeglio, LA; Johansen, T; Danne, T Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
DIABETES OBES METAB. 2023; Doi: 10.1111/dom.14987
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Giesen, N; Busch, E; Schalk, E; Beutel, G; Ruthrich, MM; Hentrich, M; Hertenstein, B; Hirsch, HH; Karthaus, M; Khodamoradi, Y; Koehler, P; Kruger, W; Koldehoff, M; Krause, R; Mellinghoff, SC; Penack, O; Sandherr, M; SeggeWiss-Bernhardt, R; Spiekermanny, K; Sprute, R; Stemler, J; Weissinger, F; Woermann, B; Wolf, HH; Cornely, OA; Rieger, CT; von Lilienfeld-Toal, M AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaXis and therapy in light of the omicron variants
EUR J CANCER. 2023; 181: 102-118. Doi: 10.1016/j.ejca.2022.11.030
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Donskov, AO; Mackie, SL; Hauge, EM; Toro-Gutierrez, CE; Hansen, IT; Hemmig, AK; Van der Maas, A; Gheita, T; Nielsen, BD; Douglas, KMJ; Conway, R; Rezus, E; Dasgupta, B; Monti, S; Matteson, EL; Sattui, SE; Matza, M; Ocampo, V; Gromova, M; Grainger, R; Bran, A; Appenzeller, S; Goecke, A; Colman, N; Keen, HI; Kuwana, M; Gupta, L; Salim, B; Harifi, G; Erraoui, M; Ziade, N; Al-Ani, NA; Ajibade, A; Knitza, J; Frolund, L; Yates, M; Pimentel-Quiroz, VR; Lyrio, AM; Sandovici, M; Van der Geest, KSM; Helliwell, T; Brouwer, E; Dejaco, C; Keller, KK An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists
RHEUMATOLOGY. 2023; Doi: 10.1093/rheumatology/keac713
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Dejaco, C; Ramiro, S; Touma, Z; Bond, M; Soowamber, M; Sanchez-Alvarez, C; Langford, CA What is a response in randomised controlled trials in giant cell arteritis?
ANN RHEUM DIS. 2023; Doi: 10.1136/ard-2022-223751
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Hohenschurz-Schmidt, D; Draper-Rodi, J; Vase, L; Scott, W; McGregor, A; Soliman, N; MacMillan, A; Olivier, A; Cherian, CA; Corcoran, D; Abbey, H; Freigang, S; Chan, JSC; Phalip, J; Sorensen, LN; Delafin, M; Baptista, M; Medforth, NR; Ruffini, N; Andresen, SS; Ytier, S; Ali, D; Hobday, H; Santosa, AANAA; Vollert, J; Rice, ASC Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article I): a systematic review and description of methods
PAIN. 2023; 164(3): 469-484. Doi: 10.1097/j.pain.0000000000002723
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Chernyshov, PV; Finlay, AY; Tomas-Aragones, L; Steinhoff, M; Manolache, L; Pustisek, N; Dessinioti, C; Svensson, A; Marron, SE; Bewley, A; Salavastru, C; Dreno, B; Suru, A; Koumaki, D; Linder, D; Evers, AWM; Abeni, D; Augustin, M; Salek, SS; Nassif, A; Bettoli, V; Szepietowski, JC; Zouboulis, CC Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa
J EUR ACAD DERMATOL. 2023; Doi: 10.1111/jdv.18918
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Pereira, MP; Weisshaar, E; Halvorsen, JA; Wallengren, J; Legat, FJ; Garcovich, S; Savk, E; Reich, A; Bozek, A; Lvov, A; Bobko, S; Metz, M; Streit, M; Misery, L; Brenaut, E; Serra-Baldrich, E; Goncalo, M; Szepietowski, JC; Augustin, M; Nau, T; Zeidler, C; Staender, S Chronic prurigo: Insufficient disease control in spite of high healthcare usage
J EUR ACAD DERMATOL. 2023; Doi: 10.1111/jdv.18903
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Odler, B; Riedl, R; Gauckler, P; Shin, JI; Leierer, J; Merkel, PA; St Clair, W; Fervenza, F; Geetha, D; Monach, P; Jayne, D; Smith, RM; Rosenkranz, A; Specks, U; Stone, JH; Kronbichler, A Risk factors for serious infections in ANCA-associated vasculitis
ANN RHEUM DIS. 2023; Doi: 10.1136/ard-2022-223401
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Hohenschurz-Schmidt, D; Draper-Rodi, J; Vase, L; Scott, W; McGregor, A; Soliman, N; MacMillan, A; Olivier, A; Cherian, CA; Corcoran, D; Abbey, H; Freigang, S; Chan, J; Phalip, J; Sorensen, LN; Delafin, M; Baptista, M; Medforth, NR; Ruffini, N; Andresen, SS; Ytier, S; Ali, D; Hobday, H; Santosa, AANAA; Vollert, J; Rice, ASC Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article II): a meta-analysis relating methods to trial results
PAIN. 2023; 164(3): 509-533. Doi: 10.1097/j.pain.0000000000002730
Web of Science PubMed FullText FullText_MUG

 

27.03.2023:

Kreuzer, M; Sames-Dolzer, E; Tulzer, A; Gierlinger, G; Mair, R; Nawrozi, MP; Grangl, G; Mair, R Long-term Follow-Up after Simultaneous Arterial Switch Operation and Aortic Arch Repair.
Eur J Cardiothorac Surg. 2023; Doi: 10.1093/ejcts/ezad038
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in WoS category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.